BioForce Nanosciences (OTCMKTS:BFNH) Releases Quarterly Earnings Results

BioForce Nanosciences (OTCMKTS:BFNH) posted its earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.

BioForce Nanosciences Stock Performance

OTCMKTS BFNH opened at $0.56 on Wednesday. BioForce Nanosciences has a fifty-two week low of $0.16 and a fifty-two week high of $2.07. The company has a market cap of $18.71 million, a P/E ratio of -55.80 and a beta of -0.89. The business’s 50 day moving average price is $0.57 and its 200-day moving average price is $0.80.

BioForce Nanosciences Company Profile

BioForce Nanosciences Holdings, Inc focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels.